⌘K

Home/Filings/4/0001104659-21-092722

4//SEC Filing

TUCHMAN ALAN J 4

Accession 0001104659-21-092722

CIK 0001571934other

View on SEC.gov Company Profile

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 6:08 PM ET

Size

4.9 KB

Accession

0001104659-21-092722

Insider Transaction Report

Form 4

Period: 2021-07-13

Synaptogenix, Inc.SNPX

DirectorChief Medical Officer

Transactions

Award
Common Stock, par value $0.0001 per share
2021-07-13+60,000→ 60,000 total

Footnotes (1)

[F1]Includes 60,000 restricted stock units granted on July 13, 2021 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date.

Documents

1 file

4
tm2122331-8_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1

filerCIK 0001417631

Filing Metadata

Form type: 4
Filed: Jul 14, 8:00 PM ET
Accepted: Jul 15, 6:08 PM ET
Size: 4.9 KB

View on SEC.gov